Albuterol Sulfate, 2.5 Mg/3 mL (0.083%) Inhalation Solution

DRUG2 trials

Sponsors

Polarean, Inc., Nemours Children's Clinic

Conditions

BronchiolitisBronchodilator AgentsChronic Obstructive Pulmonary Disease

Phase 1

Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation Imaging

Active, not recruitingNCT06271408

Polarean, Inc.Chronic Obstructive Pulmonary Disease

Start: 2024-03-19End: 2026-12-31Target: 6Updated: 2026-10-27

Phase 3

Characterization of Bronchodilator Response in Children With Bronchiolitis Using Phenotypic and Genotypic Features

RecruitingNCT06946264

Nemours Children's ClinicBronchiolitis, Bronchodilator Agents

Start: 2022-07-08End: 2030-12-31Target: 400Updated: 2026-05-08